#Roche

PFARMA
38 minutes ago

Desafio de startups da @Roche para diagnóstico de doenças raras https://t.co/jiTVzPDoZY #startup #roche #farmacêutica

Lenovo Legion x @PlayApex Now is your chance to rise above the rest. Unmatched performance, purposeful engineering, modern design. Gear up with a machine as savage as you are. Stylish outside. Savage inside.

Need a whitepaper on Hematoxylin and Eosin quality? Look no further than the one sponsored by Roche!

H&E Quality. See the Difference.

https://t.co/uPnVdXyp2b

#HandE #HandEstainquality #VENTANAHE600system #traditionallinearstainer
#Roche #Ventana #HematoxylinandEosinStaining https://t.co/CCW7sbpP65

Need a whitepaper on Hematoxylin and Eosin quality? Look no further than the one sponsored by Roche! H&E Quality. See the Difference. https://t.co/uPnVdXyp2b #HandE #HandEstainquality #VENTANAHE600system #traditionallinearstainer #Roche #Ventana #HematoxylinandEosinStaining https://t.co/CCW7sbpP65

맞팔은 선팔 멘션주면 확인하자마자 바로 해드려요! ##roche

이 계정에 대한 멘션은 폰으로 직접적인 알람이 오지않아요.. 답멘이 늦을수도 있으니 양해바래요 ㅠㅠ ##roche

잘때나 게임할때 아니고는 트윗 잘봐요! ##roche

#Roche acquires #Inflazome, along with its entire portfolio comprising of clinical and preclinical oral #NLRP3 inhibitors, at an upfront €380 million payment, along with potential contingent payments based on predetermined milestones

사볼을 주로해요! 리플렉도 주로해요! 도라도라 하고있긴한데 너무 어려워요.. ##roche

awp
10 hours ago

AC Immune et Genentech essuient un revers contre la maladie d'Alzheimer https://t.co/1rmLySp54e #ACImmuneSA #GenentechInc #Roche

awp
10 hours ago

Roche erreicht Ziele mit Alzheimer-Kandidaten Semorinemab nicht https://t.co/r0DxM3xXR1 #ACImmuneSA #GenentechInc #Roche

#Roche acquires #Inflazome, along with its entire portfolio comprising of clinical and preclinical orall #NLRP3 inhibitors, at an upfront €380 million payment, along with potential contingent payments based on predetermined milestones. https://t.co/Bc2SfCuyPr

#Roche acquires #Inflazome, along with its entire portfolio comprising of clinical and preclinical orall #NLRP3 inhibitors, at an upfront €380 million payment, along with potential contingent payments based on predetermined milestones. https://t.co/Bc2SfCuyPr

Swiss pharma company Roche is set to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m). #Roche #Inflazome #acquisition https://t.co/pSxgKyR4G4

4/4 #Regeneron a aussi un duo d'AC déjà en phase III, le #REGN-COV2, soutenu également par la Barda à hauteur de 450 M USD. Regeneron est également associé à #Roche par production et la distribution. Les produits d'AC sont une piste importante face aux incertitudes/délais vaccin

Neutralising #antibodies bind to the spike protein of #SARSCoV2. This prevents the virus from being able to enter human cells where it would replicate and do harm. #COVID19 #pandemic #Roche https://t.co/G0TKjTsBUa

Next Page